Cleared Traditional

Brainomix 360 e-MRI (K231656) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231656 · Brainomix Limited · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2023
Decision
84d
Days
Class 2
Risk

K231656 is an FDA 510(k) clearance for the Brainomix 360 e-MRI. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Brainomix Limited (Oxford, GB). The FDA issued a Cleared decision on August 30, 2023 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Brainomix Limited devices

Submission Details

510(k) Number K231656 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 2023
Decision Date August 30, 2023
Days to Decision 84 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 107d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 787
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K231656.
AccuCTP Pro
K231353 · ArteryFlow Technology Co., Ltd. · Sep 2023
OrionXR
K232189 · Hoth Intelligence, Inc. · Sep 2023
UniSyn Molecular Imaging (6-3-1)
K231047 · Convergent Imaging Solutions · Sep 2023
AIRAscore
K223180 · Airamed GmbH · Aug 2023
CUPTIMIZE™ Advanced
K231503 · DePuy Orthopaedics, Inc. · Aug 2023
SaintView
K223660 · Inviz Corporation · Aug 2023